NO951629L - Konjugat vaksine mot gruppe B streptococcus - Google Patents
Konjugat vaksine mot gruppe B streptococcusInfo
- Publication number
- NO951629L NO951629L NO951629A NO951629A NO951629L NO 951629 L NO951629 L NO 951629L NO 951629 A NO951629 A NO 951629A NO 951629 A NO951629 A NO 951629A NO 951629 L NO951629 L NO 951629L
- Authority
- NO
- Norway
- Prior art keywords
- streptococcus
- vaccine against
- conjugate vaccine
- against group
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96886692A | 1992-11-02 | 1992-11-02 | |
| PCT/US1993/010506 WO1994010317A2 (en) | 1992-11-02 | 1993-11-02 | Conjugate vaccine against group b streptococcus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO951629D0 NO951629D0 (no) | 1995-04-28 |
| NO951629L true NO951629L (no) | 1995-07-03 |
Family
ID=25514876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO951629A NO951629L (no) | 1992-11-02 | 1995-04-28 | Konjugat vaksine mot gruppe B streptococcus |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0669985A1 (no) |
| JP (1) | JPH08505282A (no) |
| KR (1) | KR100349331B1 (no) |
| AU (1) | AU689452B2 (no) |
| CA (1) | CA2146926A1 (no) |
| FI (1) | FI951979A (no) |
| HU (1) | HU220198B (no) |
| IL (1) | IL107458A0 (no) |
| NO (1) | NO951629L (no) |
| NZ (1) | NZ258684A (no) |
| PL (1) | PL177302B1 (no) |
| RU (1) | RU2209247C2 (no) |
| WO (1) | WO1994010317A2 (no) |
| ZA (1) | ZA938171B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6015889A (en) * | 1993-03-19 | 2000-01-18 | Gunnar Lindahl | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition |
| US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
| US6426074B1 (en) * | 1997-03-19 | 2002-07-30 | The Brigham And Women's Hospital Inc. | Group B Streptococcus vaccine |
| US7098182B2 (en) | 1998-07-27 | 2006-08-29 | Microbial Technics Limited | Nucleic acids and proteins from group B streptococcus |
| JP2002531054A (ja) * | 1998-07-27 | 2002-09-24 | マイクロビアル テクニクス リミティッド | Ｂ群連鎖球菌由来の核酸およびタンパク質 |
| US6890539B2 (en) | 1998-12-22 | 2005-05-10 | Microscience, Ltd. | Genes and proteins, and their use |
| KR100818815B1 (ko) * | 1998-12-22 | 2008-04-01 | 마이크로싸이언스 리미티드 | 외표면 단백질들, 그들의 유전자들 및 그들의 사용 |
| GB9910375D0 (en) | 1999-05-05 | 1999-06-30 | Lindahl Gunnar | Vaccine composition |
| ES2382893T3 (es) * | 2000-10-13 | 2012-06-14 | Id Biomedical Corporation | Antígenos BVH-A2 y BVH-3 de streptococcus del grupo B |
| WO2004080490A2 (en) * | 2003-03-07 | 2004-09-23 | Wyeth Holdings Corporation | Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections |
| PL2144924T3 (pl) | 2007-04-16 | 2017-06-30 | Minervax Aps | Szczepionka z białkiem fuzyjnym |
| CA2734340C (en) | 2008-08-28 | 2019-03-05 | Novartis Ag | Cell surface display of polypeptide isoforms by stop codon readthrough |
| CA3001433A1 (en) | 2015-10-21 | 2017-04-27 | Minervax Aps | Immunogenic fusion protein |
| CA3004631A1 (en) | 2015-12-30 | 2017-07-06 | Minervax Aps | Immunogenic complex for eliciting protective immunity against group b streptococcus |
| CA3066020A1 (en) | 2017-06-16 | 2018-12-20 | Glaxosmithkline Biologicals Sa | Method of treatment |
| CA3161857A1 (en) | 2019-11-22 | 2021-05-27 | Glaxosmithkline Biologicals Sa | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
| EP4066854A1 (en) | 2021-03-29 | 2022-10-05 | MinervaX | Immunogenic fusion protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0302887B1 (en) * | 1986-04-16 | 1994-06-22 | The Brigham And Women's Hospital, Inc. | Bacterial antigens, antibodies, vaccines, and methods of manufacture |
| IL95578A (en) * | 1989-09-15 | 1998-08-16 | Gen Hospital Corp | A vaccine made from polysaccharide and protein |
-
1993
- 1993-11-01 IL IL10745893A patent/IL107458A0/xx unknown
- 1993-11-02 ZA ZA938171A patent/ZA938171B/xx unknown
- 1993-11-02 EP EP94902202A patent/EP0669985A1/en not_active Withdrawn
- 1993-11-02 WO PCT/US1993/010506 patent/WO1994010317A2/en not_active Application Discontinuation
- 1993-11-02 PL PL93308555A patent/PL177302B1/pl not_active IP Right Cessation
- 1993-11-02 AU AU56654/94A patent/AU689452B2/en not_active Ceased
- 1993-11-02 RU RU95113472/13A patent/RU2209247C2/ru not_active IP Right Cessation
- 1993-11-02 CA CA002146926A patent/CA2146926A1/en not_active Abandoned
- 1993-11-02 JP JP6511389A patent/JPH08505282A/ja active Pending
- 1993-11-02 KR KR1019950701811A patent/KR100349331B1/ko not_active IP Right Cessation
- 1993-11-02 HU HU9501260A patent/HU220198B/hu not_active IP Right Cessation
- 1993-11-02 NZ NZ258684A patent/NZ258684A/en unknown
-
1995
- 1995-04-26 FI FI951979A patent/FI951979A/fi not_active Application Discontinuation
- 1995-04-28 NO NO951629A patent/NO951629L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08505282A (ja) | 1996-06-11 |
| AU689452B2 (en) | 1998-04-02 |
| EP0669985A1 (en) | 1995-09-06 |
| PL308555A1 (en) | 1995-08-21 |
| KR950704492A (ko) | 1995-11-20 |
| FI951979A0 (fi) | 1995-04-26 |
| WO1994010317A3 (en) | 1994-07-07 |
| HUT70981A (en) | 1995-11-28 |
| FI951979A (fi) | 1995-06-29 |
| WO1994010317A2 (en) | 1994-05-11 |
| RU2209247C2 (ru) | 2003-07-27 |
| NO951629D0 (no) | 1995-04-28 |
| ZA938171B (en) | 1995-03-07 |
| NZ258684A (en) | 1997-04-24 |
| PL177302B1 (pl) | 1999-10-29 |
| KR100349331B1 (ko) | 2003-01-06 |
| IL107458A0 (en) | 1994-02-27 |
| CA2146926A1 (en) | 1994-05-11 |
| AU5665494A (en) | 1994-05-24 |
| HU220198B (hu) | 2001-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO942867L (no) | Syntetisk haemophilus influenzae konjugat-vaksine | |
| NO951629D0 (no) | Konjugat vaksine mot gruppe B streptococcus | |
| NO921364D0 (no) | Hybridpolypeptid | |
| AU6858391A (en) | Bundle tie | |
| MX174031B (es) | Inflador hibrido | |
| DE69126606D1 (de) | Vakzine | |
| DE69307719D1 (de) | Hybridgetriebe | |
| DE69321907D1 (de) | Hybrider koppler | |
| FI944052A (fi) | Oraalinen rokote | |
| DE69309672D1 (de) | Klammerbefestigungsvorrichtung | |
| FI930631A0 (fi) | En roterande motor, foersedd med en utbalanserad vridaxel | |
| ZA937034B (en) | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines | |
| NO922728D0 (no) | Vaksine mot coccidiose | |
| NO942707D0 (no) | Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner | |
| ITVE920048A0 (it) | Dispositivo accoppiatore di motopropulsori | |
| DE4295148D2 (de) | Thermo-Magnetischer Motor | |
| FI965196A0 (fi) | HIV-infektion yhdistelmähoito | |
| DE69204500D1 (de) | Gereinigtes Milben-Allergen. | |
| GB9320943D0 (en) | Peptide-protein conjugate vaccines having anionic spacers | |
| NO971003D0 (no) | Enteral vaksine mot vaginale infeksjoner | |
| DE69304836D1 (de) | Synchronmotor | |
| AU5626998A (en) | Conjugate vaccine against group B Streptococcus | |
| NL300165I2 (nl) | Babesiavaccin. | |
| SE9602149D0 (sv) | Conjugate vaccine against streptococcus pneumoniae | |
| KR940011306U (ko) | 하이브리드 멀티 플렉서 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |